|

Olanzapine Clinical Trials

9 actively recruiting trials across 5 locations

▲ +1 trial since May 2026

Also known as: LY 170053, Zyprexa, Zyprexa Zydis, Zypreza

Pipeline

Phase 2: 4Phase 3: 4Phase 1/2: 1

Top Sponsors

  • The Hospital for Sick Children1
  • The Affiliated People's Hospital of Ningbo University1
  • Second Affiliated Hospital of Nanchang University1
  • Roswell Park Cancer Institute1
  • OHSU Knight Cancer Institute1

Indications

Other4 trials

Olanzapine Impact on First-line Immunotherapy for Advanced EGFR-negative NSCLC
Phase 2
Prevention of Delayed CINV After Autologous Transplant: Olanzapine-Containing Regimen vs. Dexamethasone-Containing Regimen
Phase 3
Sequenced Treatment Alternatives to Relieve Adolescent Depression (STAR-AD)
Phase 1/2
The Danish Out-of-Hospital Cardiac Arrest Study
Phase 3

San Francisco, California1 trial

RCT of Olanzapine for Control of CIV in Children Receiving Highly Emetogenic Chemotherapy

University of California

Phase 2

Augusta, Georgia1 trial

Olanzapine 2.5 vs 5 mg in Quadruplet Nausea/Vomiting Prophylaxis Before High-Dose Melphalan

Wellstar MCG

Phase 3

Buffalo, New York1 trial

Olanzapine for Managing Anorexia in Head and Neck Cancer Patients Undergoing Chemoradiation, MACRO Trial

Roswell Park Cancer Institute

Phase 2

Portland, Oregon1 trial

Olanzapine for the Management of Cancer Associated Appetite Loss in Patients With Advanced Esophagogastric, Hepatopancreaticobiliary, Colorectal or Lung Cancer

OHSU Knight Cancer Institute

Phase 2

Houston, Texas1 trial

Effect of Olanzapine on Opioid Craving and Misuse Among Patients Receiving Opioids for Cancer-related Pain: A Pilot Double-Blind, Randomized Control Trial

MD Anderson Cancer Center

Phase 3

Trial data from ClinicalTrials.gov. Trial status and eligibility can change — verify directly with the study contact or on ClinicalTrials.gov.

This site does not provide medical advice. Always consult your doctor before considering enrollment in a clinical trial. Learn more on our About page.